CL2007003675A1 - Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimie - Google Patents

Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimie

Info

Publication number
CL2007003675A1
CL2007003675A1 CL200703675A CL2007003675A CL2007003675A1 CL 2007003675 A1 CL2007003675 A1 CL 2007003675A1 CL 200703675 A CL200703675 A CL 200703675A CL 2007003675 A CL2007003675 A CL 2007003675A CL 2007003675 A1 CL2007003675 A1 CL 2007003675A1
Authority
CL
Chile
Prior art keywords
agent
controlled liberation
antiglucemian
bioadherent
nucleus
Prior art date
Application number
CL200703675A
Other languages
English (en)
Spanish (es)
Inventor
Funari Negrao Alexandre
Original Assignee
Medley S A Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medley S A Ind Farmaceutica filed Critical Medley S A Ind Farmaceutica
Publication of CL2007003675A1 publication Critical patent/CL2007003675A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CL200703675A 2006-12-20 2007-12-18 Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimie CL2007003675A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0605967-8A BRPI0605967A (pt) 2006-12-20 2006-12-20 composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica

Publications (1)

Publication Number Publication Date
CL2007003675A1 true CL2007003675A1 (es) 2008-06-27

Family

ID=39536766

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703675A CL2007003675A1 (es) 2006-12-20 2007-12-18 Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimie

Country Status (3)

Country Link
BR (1) BRPI0605967A (pt)
CL (1) CL2007003675A1 (pt)
WO (1) WO2008074108A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2544666A2 (en) 2010-03-09 2013-01-16 Council of Scientific and Industrial Research Gastroretentive, extended release composition of therapeutic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN192180B (pt) * 2001-09-28 2004-03-06 Ranbaxy Lab
US20030187074A1 (en) * 2002-03-04 2003-10-02 Javed Hussain Oral compositions for treatment of diabetes
WO2005092293A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Formulations of metformin

Also Published As

Publication number Publication date
BRPI0605967A (pt) 2008-08-12
WO2008074108A2 (en) 2008-06-26
WO2008074108A3 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
ECSP10010533A (es) Derivados de 4-aminociclohexano sustituido
BRPI0908208A2 (pt) Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto.
ECSP11010529A (es) Derivados de ciclohexano espirociclicos sustituidos
CY1117143T1 (el) Νεα καρβονυλιωμενα (αζα)κυκλοεξανια ως προσδετες του d3 υποδοχεα ντοπαμινης
DOP2011000076A (es) Derivados de heteroaril amidas y su uso como activadores de glucoquinasa
CL2007002121A1 (es) Compuestos derivados de pirazoles, activadores de glucoquinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que comprende dichos compuestos; y uso para el tratamiento de enfermedades y/o trastornos metabolicos, tal como diab
CL2008002873A1 (es) Anticuerpo anti-glipican 3/gpc3; composicion que lo comprende; agente anti-canceroso que lo comprende; acido nucleico que codifica dicho anticuerpo; celula hospedera aislada que comprende dicho acido nucleico; metodo para la preparacion de dicho anticuerpo
DK2282994T3 (da) 3-aminocarbazolforbindelse, farmaceutisk sammensætning indeholdende forbindelsen samt fremstillingsmetode derfor
CL2010001428A1 (es) Compuestos derivados de amidas y tioamidas heteroaromaticas; agente que contiene al menos uno de dichos compuestos; procedimiento para combatir parasitos; y uso de dichos compuestos.
CR20110309A (es) Compuestos orgánicos
CL2009000639A1 (es) Pirimidinas-5-acarboxamidas sustituidas; la composicion farmceutica que la contiene; y sus usos.
EP2399168A4 (en) CHEMICALLY REINFORCED RESISTANT COMPOSITION AND MOLDING PROCESS THEREFOR AND RESIST FILM THEREWITH
CL2012003602A1 (es) Compuestos heterociclicos nitrogenados fusionados, moduladores de fosfodiesterasas; un medicamento; un método para prevenir o tratar la esquizofrenia; y su uso para la produccion de un agente para prevenir o tratar la esquizofrenia.
EP2024334A4 (en) SUBSTITUTED ESTERS AS CANNABINOID-1 RECEPTOR MODULATORS
PE20130701A1 (es) Composicion de pigmentos solubles en agua o en solventes organicos
WO2011089595A3 (en) Sustained-release nucleic acid matrix compositions
CR10665A (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR064955A1 (es) Composicion y metodo para estabilizar ingredientes sensibles
DK2120585T3 (da) Langtidsfrigivet farmaceutisk sammensætning indeholdende vandig opløsning af bisfosfonat
EP2555772A4 (en) OXAZOLE DERIVATIVES SUITABLE AS FAAH MODULATORS
EP2332535A4 (en) SOLID PHARMACEUTICAL COMPOSITION
CL2013002971A1 (es) Compuestos derivados de 5-(fenil/piridinil-etinil)-2-piridina/2-pirimidina-carboxamida, moduladores mglur5; composición farmacéutica que los comprende; proceso de preparación de ellos; y su uso en el tratamiento de esquizofrenia o enfermedades cognitivas.
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
BRPI0913613A2 (pt) composto, medicamento, e, agente antagonizante do receptor sensível a cálcio
BRPI0914971A2 (pt) composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas